Does DUPILUMAB Cause Injection site induration? 376 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 376 reports of Injection site induration have been filed in association with DUPILUMAB (Dupixent). This represents 0.1% of all adverse event reports for DUPILUMAB.
376
Reports of Injection site induration with DUPILUMAB
0.1%
of all DUPILUMAB reports
0
Deaths
7
Hospitalizations
How Dangerous Is Injection site induration From DUPILUMAB?
Of the 376 reports, 7 (1.9%) required hospitalization.
Is Injection site induration Listed in the Official Label?
Yes, Injection site induration is listed as a known adverse reaction in the official FDA drug label for DUPILUMAB.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Injection site induration?
ETANERCEPT (1,451)
NALTREXONE (866)
ADALIMUMAB (577)
GLATIRAMER (382)
INTERFERON BETA-1A (254)
EVOLOCUMAB (229)
ENBREL (218)
LEUPROLIDE (207)
IXEKIZUMAB (177)
HYDROXYPROGESTERONE CAPROATE (158)
Which DUPILUMAB Alternatives Have Lower Injection site induration Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE